Yang C, Liu W, Powell C, Wang Q
Chin Med J Pulm Crit Care Med. 2025; 2(4):240-249.
PMID: 39834587
PMC: 11742357.
DOI: 10.1016/j.pccm.2024.08.009.
Tokhanbigli S, Haghi M, Dua K, Oliver B
Cancer Drug Resist. 2024; 7:32.
PMID: 39403603
PMC: 11472577.
DOI: 10.20517/cdr.2024.55.
Solek J, Braun M, Sadej R, Romanska H
Int J Oncol. 2024; 65(4).
PMID: 39219285
PMC: 11374155.
DOI: 10.3892/ijo.2024.5682.
Strell C, Rodriguez-Tomas E, Ostman A
Cancer Metastasis Rev. 2024; 43(4):1593-1609.
PMID: 38980580
PMC: 11554757.
DOI: 10.1007/s10555-024-10194-7.
Chen Q, Luo J, Liu J, Yu H, Zhou M, Yu L
J Tradit Complement Med. 2024; 14(3):321-334.
PMID: 38707923
PMC: 11068993.
DOI: 10.1016/j.jtcme.2023.11.008.
Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies.
Zhou Q, Jin X, Zhao Y, Wang Y, Tao M, Cao Y
Hum Mol Genet. 2024; 33(13):1186-1193.
PMID: 38538564
PMC: 11190611.
DOI: 10.1093/hmg/ddae056.
Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming.
Sari D, Gozuacik D, Akkoc Y
Front Cell Dev Biol. 2024; 11:1274682.
PMID: 38234683
PMC: 10791779.
DOI: 10.3389/fcell.2023.1274682.
Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W, Wang J, Liu C, Li Y, Sun C, Wu J
J Transl Med. 2023; 21(1):827.
PMID: 37978384
PMC: 10657029.
DOI: 10.1186/s12967-023-04714-2.
Deletion of the mRNA stability factor (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity.
McCarthy G, Di Niro R, Finan J, Jain A, Guo Y, Wyatt C
NAR Cancer. 2023; 5(2):zcad016.
PMID: 37089813
PMC: 10113877.
DOI: 10.1093/narcan/zcad016.
Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells.
Kim S, Kim H, Jeong Y, You D, Yoon S, Lo E
Biomedicines. 2023; 11(3).
PMID: 36979654
PMC: 10045855.
DOI: 10.3390/biomedicines11030675.
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6.
Lee Y, Go G, Koh E, Yoon H, Seo M, Hong S
J Immunother Cancer. 2023; 11(2).
PMID: 36849201
PMC: 9972461.
DOI: 10.1136/jitc-2022-006130.
Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment.
Xue X, Liu Y, Chen X, Tao B, Liu P, Zhou H
Front Pharmacol. 2022; 13:1064032.
PMID: 36569293
PMC: 9768042.
DOI: 10.3389/fphar.2022.1064032.
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives.
Toledo B, Picon-Ruiz M, Marchal J, Peran M
Int J Mol Sci. 2022; 23(24).
PMID: 36555218
PMC: 9778751.
DOI: 10.3390/ijms232415576.
Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor.
Yang H, Liu J, Lee J, Harn H, Chiou T
Int J Mol Sci. 2021; 22(15).
PMID: 34360896
PMC: 8348294.
DOI: 10.3390/ijms22158125.
Primary cilium and its role in tumorigenesis.
Mao H, Sun Y
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021; 50(2):245-260.
PMID: 34137221
PMC: 8710278.
DOI: 10.3724/zdxbyxb-2021-0048.
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches.
Saraon P, Pathmanathan S, Snider J, Lyakisheva A, Wong V, Stagljar I
Oncogene. 2021; 40(24):4079-4093.
PMID: 34079087
DOI: 10.1038/s41388-021-01841-2.
The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer.
Cho M, Li J, Gonzalez-Delgado R, Lee H, Vasquez M, He T
Blood Adv. 2021; 5(7):1947-1951.
PMID: 33821990
PMC: 8045495.
DOI: 10.1182/bloodadvances.2020003410.
In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets.
Walter S, Scheidt S, Nissler R, Gaisendrees C, Zarghooni K, Schildberg F
Cancers (Basel). 2021; 13(6).
PMID: 33806802
PMC: 8005121.
DOI: 10.3390/cancers13061466.
In Vitro Suppression of T Cell Proliferation Is a Conserved Function of Primary and Immortalized Human Cancer-Associated Fibroblasts.
Abuwarwar M, Baker A, Harding J, Payne N, Nagy A, Knoblich K
Int J Mol Sci. 2021; 22(4).
PMID: 33673197
PMC: 7918788.
DOI: 10.3390/ijms22041827.
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity.
Louault K, Li R, DeClerck Y
Cancers (Basel). 2020; 12(11).
PMID: 33114328
PMC: 7690906.
DOI: 10.3390/cancers12113108.